| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 03/05/2002 | US6352682 Polymeric delivery of radionuclides and radiopharmaceuticals |
| 02/28/2002 | WO2002016965A2 Radioactive emission detector |
| 02/28/2002 | WO2002016429A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | WO2002016333A2 Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
| 02/28/2002 | WO2002015943A2 Novel radiotherapeutic formulations containing 224ra and a method for their production |
| 02/28/2002 | WO2001082871A3 Method of using zinc isotope for therapy and diagnosis of colon cancer |
| 02/28/2002 | WO2001082864A3 18f-labeled choline analogs |
| 02/28/2002 | US20020025946 Acylated cyclodextrin: guest molecule inclusion complexes |
| 02/28/2002 | US20020025296 Selecting foreign gene which has been isolated from a cell or virus and which has been transferred into the cells; selecting a labelled compound which will interact selectively with a protein; administering to the cells an effective dose |
| 02/28/2002 | CA2420140A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/27/2002 | EP1181936A1 Synthesis, biological and preclinical evaluation of (D-Phe6,Leu-NHEt13,des-Met14)bombesin(6-14) analogs modified with 1,4,8,11-tetraazaundecane derivatives and labeled with technetium-99m for application in oncology |
| 02/27/2002 | EP0842193B1 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone |
| 02/27/2002 | EP0794802B1 Inclusion complex of a radiohalogenated fatty acid in a cyclodextrin |
| 02/27/2002 | CN1337886A Method for improved radiation therapy |
| 02/26/2002 | US6350758 Tropane derivatives and method for their synthesis |
| 02/26/2002 | US6350467 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 02/26/2002 | US6350466 Targeted polymerized liposome diagnostic and treatment agents |
| 02/21/2002 | WO2002014369A2 Human kininogen d5 domain polypeptides and their use |
| 02/21/2002 | WO2002013875A2 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 02/21/2002 | WO2002013828A1 A retroviral immunotherapy |
| 02/21/2002 | WO2001080906A9 Radiometal complexes of 2-pyrrolylthiones for imaging a therapy |
| 02/21/2002 | WO2001070807A3 G-protein associated molecules |
| 02/21/2002 | WO2001060820A3 Matrix metalloproteinase inhibitors and uses thereof |
| 02/21/2002 | WO2001044205A3 Phenanthryl piperazinyl dicarboxylic acids as selective nmda receptor modulating agents |
| 02/21/2002 | WO2000078355A3 Biologically active materials |
| 02/21/2002 | US20020022781 Products and methods for brachytherapy |
| 02/21/2002 | US20020022590 Useful as antibiotics; reduced tissue accumulation and/or nephrotoxicity when administered to a mammal; useful against vancomycin-resistant microorganisms |
| 02/21/2002 | US20020022137 Plastic overcoated with iridium film |
| 02/21/2002 | US20020022031 Immunotherapy for chronic myelocytic leukemia |
| 02/21/2002 | US20020022003 Method and composition for the treatment of cancer by the enzymantic conversion of soluble radioactive toxic precipitates in the cancer |
| 02/21/2002 | US20020022002 Diagnosis of Alzheimer's disease |
| 02/21/2002 | CA2431954A1 A retroviral immunotherapy |
| 02/21/2002 | CA2419259A1 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 02/20/2002 | EP1180034A1 Novel epidermal growth factor receptor-binding compounds for positron emission tomography |
| 02/19/2002 | US6348185 Functional moiety linking peptide to diagnostic or pharmaceutically active substance and which confers target cell specificity to said compound; radiotherapy and drug delivery; conjugate coordination and covalent complexes; |
| 02/19/2002 | US6348184 Contacting inert support material with aqueous solution of radioactive salt of phosphoric acid, whereby radioactive salt is adsorbed on support material and converting salt to corresponding radioactive salt of pyrophosphoric acid |
| 02/19/2002 | US6347443 Method of making a hollow-tube precursor brachytherapy device |
| 02/14/2002 | WO2002012467A2 Drug metabolizing enzymes |
| 02/14/2002 | WO2002012347A1 Immunotherapy for chronic myelocytic leukemia |
| 02/14/2002 | WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | WO2002011772A2 Radiolabelled metal transport proteins as imaging agents |
| 02/14/2002 | WO2002011715A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 02/14/2002 | WO1995029669A3 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical |
| 02/14/2002 | US20020019366 Tumor radiosensitization and/or chemopotentiation using isocoumarin derivatives |
| 02/14/2002 | US20020018752 Ablation disease by cutting, blocking blood supply to tissue |
| 02/14/2002 | US20020018751 Cellular and serum protein anchors for diagnostic imaging |
| 02/14/2002 | US20020018750 Anticancer agents |
| 02/14/2002 | US20020018749 High avidity polyvalent and polyspecific reagents |
| 02/14/2002 | US20020018748 Method for targeted radiotherapy, pain palliation and imaging of osteoblastic skeletal tumors and composition therefore |
| 02/14/2002 | CA2419036A1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | CA2418383A1 Radiolabelled metal transport proteins as imaging agents |
| 02/14/2002 | CA2418369A1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | CA2418014A1 Immunotherapy for chronic myelocytic leukemia |
| 02/14/2002 | CA2417769A1 Drug metabolizing enzymes |
| 02/14/2002 | CA2417098A1 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 02/13/2002 | EP1178838A2 Macromolecular carrier for drug and diagnostic agent delivery |
| 02/13/2002 | EP1178826A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 02/13/2002 | EP0614379B1 Technetium-99m labeled peptides for imaging |
| 02/13/2002 | CN1335887A Angiocidin: A Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor |
| 02/13/2002 | CN1335779A The preparation and use of radium-223 to target calcified tissues for pain palliation bone cancer therapy, and bone surface conditioning |
| 02/12/2002 | CA2094380C Radiolabelling |
| 02/07/2002 | WO2002010192A2 Somatostatin analogues |
| 02/07/2002 | WO2002009771A1 Radiopharmaceutical for diagnostic imaging containing a technetium-99m nitride heterocomplex |
| 02/07/2002 | WO2001066155A8 Actinium-225 complexes and conjugates for radioimmunotherapy |
| 02/07/2002 | WO2001060417A3 Radioactive therapeutic liposomes |
| 02/07/2002 | WO2001002021A3 A radiolabeled mammalian tachykinin peptide analogue |
| 02/07/2002 | US20020015705 Three-step pretargeting methods and compounds |
| 02/07/2002 | US20020015704 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
| 02/07/2002 | US20020015680 A compound, comprising: a targeting moiety and a chelator, wherein the targeting moiety is bound to the chelator, is a qinolone nonpeptide, and binds to a receptor that is upregulated during angiogenesis |
| 02/07/2002 | US20020015679 Bioconjugates of nanoparticles as radiopharmaceuticals |
| 02/07/2002 | CA2319694A1 Compound |
| 02/06/2002 | EP1177009A1 Methods for forming a radioactive stent |
| 02/06/2002 | EP1176988A1 Radioactive cisplatin in the treatment of cancer |
| 02/06/2002 | EP1176981A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 02/06/2002 | CN1078815C Microparticle agent made of biological degradable copolymer |
| 02/05/2002 | US6344339 Monoclonal antibodies against the extracellular domain of human VEGF-receptor protein (KDR) |
| 02/05/2002 | US6344179 Bind to dopamine transporter with high affinity and selectivity; useful as diagnostic and therapeutic agents; containing radioactive isomers f18 or 19; pet scanning |
| 02/05/2002 | US6344178 Prepared from a permanganate, pertechnate or perrhenate, carbon monoxide, water or a halide and optionally a ligand; labelling of biologically active substrates and other ligands |
| 02/05/2002 | US6343602 Method of and a device for dry application of substances on inhalable pulverulent carrier substances |
| 02/05/2002 | CA2127284C Protein- and peptide-metal ion pharmaceutical applications |
| 01/31/2002 | WO2002008293A2 Multivalent target binding protein |
| 01/31/2002 | WO2002008287A2 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 01/31/2002 | WO2002007784A2 CARRIER-FREE 103Pd BRACHYTHERAPY SEEDS |
| 01/31/2002 | WO2002007783A2 Radiolabeled immunotoxins |
| 01/31/2002 | WO2002007782A2 Diagnosis of liver disease |
| 01/31/2002 | WO2002007781A2 Amyloid targeting imaging agents and uses thereof |
| 01/31/2002 | WO2001083693A8 Compounds having affinity for the vascular endothelial growth factor receptor-2 (vegfr-2) and associated uses |
| 01/31/2002 | WO2001062784A3 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 01/31/2002 | WO2001060416A3 Matrix metalloproteinase inhibitors as targeting components in diagnostic agents |
| 01/31/2002 | US20020012931 High specificity marker detection |
| 01/31/2002 | US20020012631 As imaging agents for the diagnosis of cardiovascular disorders such as thromboembolic disease or atherosclerosis, infectious disease and cancer |
| 01/31/2002 | CA2417185A1 Multivalent target binding protein |
| 01/31/2002 | CA2417097A1 Diagnosis of liver disease |
| 01/31/2002 | CA2416733A1 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 01/31/2002 | CA2416617A1 Amyloid targeting imaging agents and uses thereof |
| 01/31/2002 | CA2413822A1 Carrier-free 103pd brachytherapy seeds |
| 01/30/2002 | EP1176201A2 Platelet-specific chimeric immunoglobulin |
| 01/30/2002 | EP1175416A1 Heteroaryl diazacycloalkanes, their preparation and use |
| 01/30/2002 | EP1175388A1 Spect imaging agents for serotonin transporters |